User: Guest

GENE AMPLIFICATION TECHNOLOGIES

Global Market Trajectory & Analytics

MCP-1102

VALIDATED EXECUTIVE ENGAGEMENTS

POOL + OUTREACH

4227
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

761
Interactions with Platform & by Email

PARTICIPANTS

127
Unique # Participated

VALIDATIONS

57
Responses Validated*
* Login to view program details and full enterprise executive list.

DATE

JULY 2020

TABLES

57

PAGES

96

EDITION

17

PRICE

USD $5600


The global market for Gene Amplification Technologies is forecast to witness revenues spike by over 31.7% in the year 2020 and thereafter continue to grow to reach US$6.8 billion by the year 2027, trailing a post COVID-19 CAGR of 11.4% over the analysis period 2020 through 2027. Gene amplification typically uses Polymerase Chain Reaction (PCR) which remains the most commonly used and effective technology since it permits researchers to obtain lots of gene replicas quickly. Fueled by the introduction of novel PCR instruments for the detection of several critical diseases, Polymerase Chain Reaction (PCR) continues to dominate the gene amplification market. Polymerase chain reaction technology was introduced to the market in 1980s. The technology is used to detect the type and amount of virus or bacteria present in biological samples and also allows amplification of genetic material in large quantities.


In the midst of the ongoing pandemic, diagnostic and antibody tests hold a critical role in identifying people with COVID-19 infection to support isolation or quarantine measures. These tests are expected to help governments in rapidly identifying and isolating infected people and tracking contacts to manage the situation. Molecular diagnostic tests available on the market rely on RT-PCR technology to target specific genomic parts of the virus for accurate, reliable detection. PCR-based techniques are capable of detecting low quantities of viral RNA to deliver high sensitivity and allow timely diagnosis of the COVID-19 infection. Current growth in the gene amplification market is therefore being driven by qPCR technique, closely followed by RT-PCR (Reverse Transcription PCR), the two most widely used testing technologies for COVID-19 disease. A lion's share of the millions of COVID-19 tests performed worldwide is accounted for by PCR based tests. Polymerase Chain Reaction (PCR) remains the most commonly used & effective technology for gene amplification as the technology permits researchers to create lots of gene replicas very quickly. The technology allows amplification of genetic material in large quantities and is cost-effective & has a rapid turnover rate. 10 months into the pandemic & with infections continuing to spread, the focus on testing, testing & testing promises to raise revenue potential for the technology by a massive 31.7% in the year 2020. Regionally, North America represents the largest market for PCR and is expected to retain its dominance, with the US remaining the single largest market.


The market also stands to benefit from the growing popularity of molecular diagnostics for cancer screening and infectious disease testing such as hepatitis B and C, HIV, flu virus and human papilloma virus. According to the W.H.O, more than 10 million people are expected to die of cancer by the year 2026. The market for oncology-specific molecular diagnostics is dominated by breast cancer, which has a share of 15% in the overall test volumes. There are several commercialized molecular diagnostic products available for breast cancer. Fastest growth in future however is expected to be reported by colorectal cancer. Molecular diagnostic markets for prostate cancer and liver cancer are also anticipated to see major growth in the coming years due to increasing prevalence of these cancer types. People suffering from various infectious diseases, such as GI, STDs, and respiratory diseases are also increasing in numbers. These grave statistics, though alarming, represent growth drivers for the latest diagnostic techniques and devices, including molecular diagnostics based on gene amplification. PCR assays detect the presence of organisms such as Chlamydia, mycoplasmas, mycobacteria, Herpes viruses and enteroviruses from clinical specimens. Commercial PCR assays for the diagnosis of tuberculosis and C. trachomatis infection are routinely used in diagnostic laboratories. PCR assay also detects antimicrobial resistance and are used to identify the cause of infection.

Abbott Molecular, Inc.; Agilent Technologies, Inc.; Becton, Dickinson and Company; bioMerieux SA; Bio-Rad Laboratories, Inc.; Cepheid; Charles River Laboratories International, Inc.; Eppendorf AG; F. Hoffmann-La Roche AG; GE Healthcare; PerkinElmer, Inc.; Promega Corporation; QIAGEN NV; Roche Diagnostics Corporation; Sysmex Corporation; Takara Bio, Inc.
» Application (Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety, Other Applications)
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » Spain » Russia » and Rest of Europe » Asia-Pacific » Australia » India » South Korea » and Rest of Asia-Pacific » Latin America » Argentina » Brazil » Mexico » and Rest of Latin America » Middle East » Iran » Israel » Saudi Arabia » United Arab Emirates » and Rest of Middle East » and Africa

INSIDER ACCESS PRIVILEGES

Users of our portal have insider access to our data stacks based on project relevance and engagement status. Tiered access is offered to data stacks, managed based on user status - Opt-in, Active Panelist, Inactive Panelist, Active Client or Inactive Client.

ACTIVE CLIENT

INACTIVE CLIENT

ACTIVE PANELIST

INACTIVE PANELIST

OPT-INS

FEATURED COMPANIES

Registration is required to access our data stacks.

WORLD BRANDS

Registration is required to access our data stacks.

EXECUTIVES ENGAGED

Registration is required to access our data stacks.

KEY DIFFERENTIATORS

We are firmly committed to build upon perspectives from global executive insights. These engagements enrich our projects. Our primary research programs are fully validated and accessible by clients. (Its a common industry-wide* practice that no validated primary research is done! For the most part, remote resident analysts curate and write reports drawing on search engine research and data modeling.

* A review of 262 off-the-shelf market report publishers worldwide.

WHAT SETS US APART
Client companies can access multiple features on our MarketGlass™ platform.

Clients have full-stack insider access to our ongoing primary research program. We have a very successful incentive driven primary research program that benefits participating executives regardless of their purchase decision. Our platform presents a unique opportunity to collaborate with peers and review competitors’ inputs and response clusters.

Detailed engagement stats are presented for every company and executive contacted. This is made available for our client reviews. (no other publisher offers this!)

A full-stack access to clients of all primary and secondary source content. This can often run into thousands of pages.

Where relevent and possible we present competitive brands.

Peer-to-peer online interactive collaborations. Allows for team curated bespoke analytics.

Customers can update and build bespoke versions of our analytics. Bespoke updates are fulfilled within a two-day turnaround.

Discretely bounce off queries to participant pool of executives. Our embedded AI selectively pings participants geographically and by domain acumen.

We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.

Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.

All updates are offered for one year from date of your purchase without charge. Clients can opt for annual auto renewal and stay current without interruption.

  
05
1. MARKET OVERVIEW
A Prelude to Gene Amplification
Gene Amplification Technologies Market Poised to Register Rapid Growth
Polymerase Chain Reaction (PCR) The Most Widely used Gene Amplification Technology
US Dominates the Gene Amplification Market
Rise in COVID-19 Cases Drives the Demand for Gene Amplification Technologies
EXHIBIT: Top Countries Affected by COVID-19 Outbreak: Total Cases and Cases Per Million Population
COVID-19 and the Diagnostics
COVID-19 Diagnostic Test Platforms
Fighting the COVID-19 War with Molecular Diagnostics
Introduction to COVID-19 Testing
Diagnostic Tests
Antibody Tests
RT-PCR Emerges as an Effective Test to Combat COVID-19 Pandemic
RT-LAMP Assays Present Opportunity to Fast-Track and Push COVID-19 Testing
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Growth in Number of Genomics Projects Propels Market Growth
Genomic Initiatives in Select Countries
EXHIBIT: Total VC Funding (In US$ Million) in Genetics for the Years 2014, 2015, 2016, 2017 and 2018
Advances in Genome Sequencing to Spur the Gene Amplification Market
Molecular Diagnostics Progress to Increase Demand for Gene Amplification Technologies
Factors Driving Molecular Diagnostics Market
Oncology Molecular Diagnostics to Witness Rapid Growth
PCR Technology Leads the MDx Market
Prospects for Genetic Diagnostics and Testing Grow Brighter
List of Select FDA-Cleared Genetic Tests by Disease
Increasing Incidence of Infectious Diseases Results in Increased Demand for Gene Amplification Technologies
PCR Plays a Vital Role in the Diagnosis of Infectious Diseases
Emergence of LAMP as Alternative to RT-PCR
Advanced DNA Amplification Technique Works at Body Temperature
Burgeoning Geriatric Population - A Key Demand Driver for Gene Amplification Technologies
Global Population of 65+ Individuals (In 000s) by Region for the Years 2015, 2020 & 2025
Growing Incidence of Hospital Acquired Infections Propels Market Growth
Advent of Isothermal DNA Amplification Techniques
Isothermal Amplification Method Gaining Traction in Field Applications
Loop-Mediated Isothermal Amplification
New CRISPR-Based System
Gene Amplification Plays Pivotal Role in Diagnosing Inherited Conditions
Nucleic Acid Amplification Methods for Detection of Antimicrobial Resistance
PCR-Based Nucleic Acid Amplification for Detection of Antimicrobial Agents
Increase in Number and Complexity of Foodborne Outbreaks: Food Safety Testing Market Positioned for Growth
Foodborne Illness Outbreak Investigations in the US (2019 & 2020)
An Insight into Food Safety Testing Market by Technology
Real-time PCR/qPCR Technologies Fundamental in Food Safety Testing
Growing Concerns over GMOs Demand Rapid Tests for GMOs Detection
Technology Advancements
Advanced DNA Amplification Technique Works at Body Temperature
New England Biolabs Launches Rapid Colorimetric LAMP Assay Kit to Expedite COVID-19 Diagnostic Testing to Just 30 Minutes
Molecular Diagnostics in Water and Food Safety AnalysisExisting Challenges and New Developments
Molecular DiagnosticsFuture Applications
Commercialized Isothermal Amplification Methods for Water and Food Analysis
4. GLOBAL MARKET PERSPECTIVE
World Current & Future Analysis for Gene Amplification Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
World Historic Review for Gene Amplification Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
World 15-Year Perspective for Gene Amplification Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
World Current & Future Analysis for Medical & Pharma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
World Historic Review for Medical & Pharma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
World 15-Year Perspective for Medical & Pharma by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Forensic & Identity Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
World Historic Review for Forensic & Identity Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
World 15-Year Perspective for Forensic & Identity Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Agricultural & Food Safety by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
World Historic Review for Agricultural & Food Safety by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
World 15-Year Perspective for Agricultural & Food Safety by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
GEOGRAPHIC MARKET ANALYSIS
United States
USA Current & Future Analysis for Gene Amplification Technologies by Application - Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
USA Historic Review for Gene Amplification Technologies by Application - Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
USA 15-Year Perspective for Gene Amplification Technologies by Application - Percentage Breakdown of Value Sales for Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications for the Years 2012, 2020 & 2027
US Witnesses Strong Wave of New Diagnostic Tests amid COVID-19 Pandemic
Rising Cancer Cases Spur Growth in Gene Amplification Technology Market
Estimated Number of New Cancer Cases and Deaths in the US (2019)
Growing Molecular Diagnostics Market Drives the Demand for Gene Amplification Technologies
Rapidly Ageing Population: A Major Driving Demand for Gene Amplification Technologies
EXHIBIT: North American Elderly Population by Age Group (1975-2050)
EXHIBIT: Aging Population in the US (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population
Canada
Canada Current & Future Analysis for Gene Amplification Technologies by Application - Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
Canada Historic Review for Gene Amplification Technologies by Application - Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
Canada 15-Year Perspective for Gene Amplification Technologies by Application - Percentage Breakdown of Value Sales for Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications for the Years 2012, 2020 & 2027
High Focus on Improving Healthcare Augurs Well for Market Growth
Number of New Cancer Cases in Canada: 2019
Japan
Japan Current & Future Analysis for Gene Amplification Technologies by Application - Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
Japan Historic Review for Gene Amplification Technologies by Application - Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
Japan 15-Year Perspective for Gene Amplification Technologies by Application - Percentage Breakdown of Value Sales for Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications for the Years 2012, 2020 & 2027
Increasing Need for Geriatric Healthcare and Cancer Care to Drive Demand for Gene Amplification Market
EXHIBIT: Japanese Population by Age Group (2015 & 2040): Percentage Share Breakdown of Population for 0-14, 15-64 and 65 & Above Age Groups
EXHIBIT: Cancer Related Incidence and Deaths by Site in Japan: 2018
China
China Current & Future Analysis for Gene Amplification Technologies by Application - Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
China Historic Review for Gene Amplification Technologies by Application - Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
China 15-Year Perspective for Gene Amplification Technologies by Application - Percentage Breakdown of Value Sales for Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications for the Years 2012, 2020 & 2027
Rising Cancer Incidence Drives the Gene Amplification Market
Number of New Cancer Cases Diagnosed (in Thousands) in China: 2018
Europe
Europe Current & Future Analysis for Gene Amplification Technologies by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
Europe Historic Review for Gene Amplification Technologies by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
Europe 15-Year Perspective for Gene Amplification Technologies by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
Europe Current & Future Analysis for Gene Amplification Technologies by Application - Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
Europe Historic Review for Gene Amplification Technologies by Application - Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
Europe 15-Year Perspective for Gene Amplification Technologies by Application - Percentage Breakdown of Value Sales for Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications for the Years 2012, 2020 & 2027
Rising Cancer Incidence Drives the European Gene Amplification Market
Cancer Incidence in Europe: Number of New Cancer Cases (in Thousands) by Site for 2018
France
France Current & Future Analysis for Gene Amplification Technologies by Application - Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
France Historic Review for Gene Amplification Technologies by Application - Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
France 15-Year Perspective for Gene Amplification Technologies by Application - Percentage Breakdown of Value Sales for Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications for the Years 2012, 2020 & 2027
Germany
Germany Current & Future Analysis for Gene Amplification Technologies by Application - Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
Germany Historic Review for Gene Amplification Technologies by Application - Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
Germany 15-Year Perspective for Gene Amplification Technologies by Application - Percentage Breakdown of Value Sales for Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications for the Years 2012, 2020 & 2027
Italy
Italy Current & Future Analysis for Gene Amplification Technologies by Application - Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
Italy Historic Review for Gene Amplification Technologies by Application - Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
Italy 15-Year Perspective for Gene Amplification Technologies by Application - Percentage Breakdown of Value Sales for Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications for the Years 2012, 2020 & 2027
United Kingdom
UK Current & Future Analysis for Gene Amplification Technologies by Application - Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
UK Historic Review for Gene Amplification Technologies by Application - Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
UK 15-Year Perspective for Gene Amplification Technologies by Application - Percentage Breakdown of Value Sales for Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications for the Years 2012, 2020 & 2027
Rest of Europe
Rest of Europe Current & Future Analysis for Gene Amplification Technologies by Application - Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
Rest of Europe Historic Review for Gene Amplification Technologies by Application - Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
Rest of Europe 15-Year Perspective for Gene Amplification Technologies by Application - Percentage Breakdown of Value Sales for Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications for the Years 2012, 2020 & 2027
Asia-Pacific
Asia-Pacific Current & Future Analysis for Gene Amplification Technologies by Application - Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
Asia-Pacific Historic Review for Gene Amplification Technologies by Application - Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
Asia-Pacific 15-Year Perspective for Gene Amplification Technologies by Application - Percentage Breakdown of Value Sales for Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications for the Years 2012, 2020 & 2027
Growing Incidence of Cancer in Asia-Pacific to Propel the Demand for Gene Amplification Market
Cancer Incidence in Asia: Number of New Cancer Cases (in Thousands) for 2019
Rest of World
Rest of World Current & Future Analysis for Gene Amplification Technologies by Application - Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
Rest of World Historic Review for Gene Amplification Technologies by Application - Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
Rest of World 15-Year Perspective for Gene Amplification Technologies by Application - Percentage Breakdown of Value Sales for Medical & Pharma, Forensic & Identity Testing, Agricultural & Food Safety and Other Applications for the Years 2012, 2020 & 2027
Total Companies Profiled : 90

Click here to request a full table of contents and more details on this project.

INSIDER ACCESS TO

 METHODOLOGY  QUESTIONNAIRE  INFLUENCER NETWORK

Registration is required to access our data stacks.

RESEARCH PANEL

Panelists are carefully chosen based on their domain expertise and market influence.

Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.

Our panelists give 30-minutes a month or a one-time 30-minute participation based on their time and willingness.

  • Complimentary previews of full stack research data for participated
  • Insider access to research programs including engagements and stats from other panelists
  • Unlimited research credits of $1000 per participated project
  • Competitive Intelligence Alerts including engagements from other panelists and validated participants worldwide relevant to your company
  • Interact with other panelists via our MarketGlassTM Data Exchange Platform*
  • BlogX - Panelists can use our blogging platform publish their viewpoints on news relevant to their domain expertise. Platform enables panelists to share their viewpoints on current news and events related to their areas domain expertise with timely and insightful blogs*

* Complete details will be shared with panelists upon formal acceptance.

 GLOBAL EXPERT PANEL

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com